Skip to main content
. 2022 Jan 21;12(2):577–589. doi: 10.1007/s13555-021-00664-z

Table 1.

Inclusion/exclusion criteria

Inclusion criteria Exclusion criteria
Male and female > 16 years old Known sensitivity to any compound of the investigational product
Suffering from mild to moderate acne Pregnant
The last treatment was at least 2 months before Serious intercurrent infection or another active disease up to 3 months before study entry
Subjects not responsive to other previous treatments, either systemic and topical or phototherapy History of concurrent malignancy
Subjects accepting to follow the instruction received by the investigator and disposable and able to return to the study center at the established times Significant psychosocial or psychiatric disorders that may impair the subject’s ability to meet the study requirements
Subjects accepting to not receive any drugs/cosmetics treatment able to interfere with the study results Significant concurrent medical disorders that may impair the subject’s ability to participate over the whole 1 year of the study
No participation in a similar study currently or during the previous 6 months Any other medical condition that in the Investigator’s opinion would prevent the subject from participating in the study
Subjects for which the informed consent form has been signed